Comparison of Perioperative Ranibizumab Injections for Diabetic Macular Edema in Patients Undergoing Cataract Surgery

Table 3

Changes of clinical parameters during the follow-up in study groups.

	Va0	Va1	Va3	FT0	FT1	FT3	To0	To1	To3
1	0.70 ± 0.79	0.45 ± 0.43	0.45 ± 0.43	354.5 ± 87.7	439.7 ± 113.7	413.3 ± 110.6	16,0 ± 4.6	16,1 ± 4.6	15,2 ± 3.0
2	0.88 ± 0.88	0.63 ± 0.72	0.67 ± 0.69	374.1 ± 81.7	392.0 ± 74.2	443.4 ± 126.2	17,0 ± 2.6	16,5 ± 1.6	16,5 ± 1.2
3	0.60 ± 0.65	0.45 ± 0.53	0.60 ± 0.74	356.1 ± 117.4	406.0 ± 129.7	434.6 ± 97.4	17,8 ± 2.2	17,6 ± 4.1	15,7 ± 1.9

Mean-standard deviation.
Va₀ = best corrected visual acuity at baseline (Log MAR), Va₁ = best corrected visual acuity at 1st month (Log MAR), Va₃ = best corrected visual acuity at 3rd month (Log MAR), FT₀ = foveal thickness at baseline, FT₁ = foveal thickness at 1st month, FT₃ = foveal thickness at 3rd month, To₀ = intraocular pressure at baseline, To₁ = intraocular pressure at 1st month, and To₃ = intraocular pressure at 3rd month.